X0202 4 2007-12-31 0001096385 VECTREN CORP VVC 0001180873 ELLERBROOK NIEL C ONE VECTREN SQUARE P. O. BOX 209 EVANSVILLE IN 47708 1 1 0 0 Chm, Pres & CEO Common Stock 2007-12-20 5 G 0 E 12270 0 D 178145.759 D Common Stock 2007-12-31 4 J 0 40300 0 D 137845.759 D Common Stock 2007-12-31 4 F 0 7500 0 D 130345.759 D Common Stock 199 I By Spouse Common Stock 1100 I IRA Phantom Stock 2008-01-01 4 A 0 55000 0 A Common Stock 55000 55000 D A bona fide gift of securities to charitable organizations exempt under Section 16(b) by virtue of Rule 16(b)-5. This disposition represents the performance adjustment forfeiture relating to the January 1, 2005 grant under the Vectren Corporation At-Risk Compensation Plan. This grant is exempt under Section 16b-2 and was previously approved by the Board of Directors. This grant is subject to forfeiture as provided under the Plan. The Stock Unit Award was acquired pursuant to the Vectren Corporation At-Risk Compensation Plan and is subject to forfeiture as provided by the plan. The lifting of restrictions and forfeitability provisions are dependent upon performance during a measurement period from 1/1/08 through 12/31/10 and continued employment until 12/31/11. Upon lifting of restrictions, Grantee shall be paid, for each Stock Unit Award, in cash, the Fair Market Value of one share of common stock on the date restrictions lapse, provide Grantee is in compliance with share ownership guidelines established by the board of directors. If Grantee is not in compliance with share ownership guidelines, the value of each Stock Unit Award shall be paid in unrestricted Vectren common stock. The board of directors approved the acquisition in accordance with Rule 16b-3(d). Given the performance-based nature of the award, it is possible that this award is not a derivative security and may not be reportable. The reporting person elected not to defer restricted stock vesting in 2007 resulting in the sale of securities to cover tax withholding due upon the lifting of restrictions and receipt of shares. This transaction was previously approved by the Compensation and Benefits Committee of the Board of Directors and is exempt under Rule 16b-3. Ronald E. Christian 2008-01-03